CDC-NCHSTP-DHAP: HIV/AIDS Surveillance Supplemental Report

National Center for HIV, STD and TB Prevention
Divisions of HIV/AIDS Prevention

Table 1. Estimated numbers of diagnosed cases of HIV/AIDS, by race/ethnicity, sex, exposure category, and age category, 1999–2002—30 areas with confidential name-based HIV infection reporting

White, not Hispanic
		Year of diagnosis
Exposure category	1999	2000	2001	2002
Male adult or adolescent
Male-to-male sexual contact	4,712	5,026	5,182	5,446
Injection drug use	715	647	618	639
Male-to-male sexual contact and injection drug use	486	437	397	421
Heterosexual contact	394	394	381	407
Other^a	66	71	64	73
Subtotal	6,372	6,575	6,642	6,987

Female adult or adolescent
Injection drug use	414	433	399	382
Heterosexual contact	885	929	943	928
Other^a	30	26	27	27
Subtotal	1,329	1,389	1,369	1,337

Total adults and adolescents	7,702	7,963	8,011	8,324

Child (<13 yrs)
Perinatal	16	19	27	19
Other^a	0	1	1	5
Subtotal	16	21	29	24

Total	7,718	7,984	8,040	8,347

Black, not Hispanic
		Year of diagnosis
Exposure category	1999	2000	2001	2002
Male adult or adolescent
Male-to-male sexual contact	3,937	3,980	4,187	4,464
Injection drug use	1,851	1,787	1,599	1,642
Male-to-male sexual contact and injection drug use	452	384	423	396
Heterosexual contact	2,449	2,401	2,364	2,353
Other^a	80	74	77	70
Subtotal	8,769	8,627	8,651	8,925

Female adult or adolescent
Injection drug use	1,088	993	937	895
Heterosexual contact	4,310	4,281	4,273	4,376
Other^a	87	103	88	88
Subtotal	5,486	5,377	5,298	5,359

Total adults and adolescents	14,255	14,004	13,949	14,284

Child (<13 yrs)
Perinatal	135	114	133	102
Other^a	7	11	8	12
Subtotal	142	125	141	114

Total	14,397	14,129	14,090	14,398

Hispanic
		Year of diagnosis
Exposure category	1999	2000	2001	2002
Male adult or adolescent
Male-to-male sexual contact	1,164	1,315	1,394	1,605
Injection drug use	414	447	425	436
Male-to-male sexual contact and injection drug use	107	117	97	108
Heterosexual contact	340	391	387	432
Other^a	16	19	24	18
Subtotal	2,041	2,289	2,327	2,600

Female adult or adolescent
Injection drug use	124	131	121	121
Heterosexual contact	429	468	516	560
Other^a	11	15	15	20
Subtotal	564	614	651	701

Total adults and adolescents	2,605	2,903	2,978	3,301

Child (<13 yrs)
Perinatal	21	18	29	19
Other^a	5	0	4	1
Subtotal	27	18	33	20
Total	2,631	2,920	3,012	3,321

Asian/Pacific Islander
		Year of diagnosis
Exposure category	1999	2000	2001	2002
Male adult or adolescent
Male-to-male sexual contact	58	75	68	75
Injection drug use	10	18	17	17
Male-to-male sexual contact and injection drug use	2	4	5	4
Heterosexual contact	19	19	15	20
Other^a	2	2	1	2
Subtotal	91	118	105	118

Female adult or adolescent
Injection drug use	5	5	4	3
Heterosexual contact	26	26	28	25
Other^a	1	2	3	1
Subtotal	32	32	34	29

Total adults and adolescents	123	150	139	147

Child (<13 yrs)
Perinatal	0	0	1	2
Other^a	0	0	0	0
Subtotal	0	0	1	2

Total	123	150	140	149

American Indian/Alaska Native
		Year of diagnosis
Exposure category	1999	2000	2001	2002
Male adult or adolescent
Male-to-male sexual contact	67	58	60	75
Injection drug use	14	15	22	16
Male-to-male sexual contact and injection drug use	12	13	18	10
Heterosexual contact	15	15	10	12
Other^a	1	0	0	0
Subtotal	109	101	110	114

Female adult or adolescent
Injection drug use	13	13	10	16
Heterosexual contact	29	32	20	37
Other^a	1	1	3	0
Subtotal	43	46	32	53

Total adults and adolescents	153	147	142	167

Child (<13 yrs)
Perinatal	0	0	0	1
Other^a	0	0	0	0
Subtotal	0	0	0	1

Total	153	147	142	168

		Year of diagnosis
	1999	2000	2001	2002

Total cases^b	25,174	25,522	25,643	26,464

Note. These numbers do not represent actual cases in persons with a diagnosis of HIV/AIDS. Rather, these numbers are point estimates of cases diagnosed that have been adjusted for reporting delays and for redistribution of cases in persons initially reported without an identified risk. The estimates have not been adjusted for incomplete reporting. Because column totals were calculated independently of the values for the subpopulations, the values in each column may not sum to the column total.
Data include persons with a diagnosis of HIV infection. This includes persons with a diagnosis of HIV infection(not AIDS), a diagnosis of HIV infection and a later AIDS diagnosis, and concurrent diagnoses of HIV infection and AIDS.

Since 1998, the following 30 areas have had laws or regulations requiring confidential name-based HIV infection reporting: Alabama, Arkansas, Arizona, Florida, Colorado, Iowa, Idaho, Indiana, Louisiana, Michigan, Minnesota, Mississippi, Missouri, Nebraska, New Jersey, New Mexico, Nevada, North Carolina, North Dakota, Ohio, Oklahoma, South Carolina, South Dakota, Tennessee, Utah, Virginia, Wisconsin, West Virginia, Wyoming, and the U.S. Virgin Islands. Since July 1997, Florida has had confidential name-based HIV infection reporting only for new diagnoses.
^a Includes hemophilia, blood transfusion, and risk not reported or not identified.
^b Includes persons of unknown race or multiple races and persons of unknown sex.

Added on: June 5, 2004
Centers for Disease Control & Prevention
National Center for HIV, STD, and TB Prevention
Divisions of HIV/AIDS Prevention
Contact Us